NASDAQ: ATHEAlterity Therapeutics Revenue
Alterity Therapeutics revenue was $4.99M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, ATHE annual revenue was $5.0M, with 87.6% growth year-over-year.
ATHE past revenue growth
How has ATHE's revenue growth performed historically?
Company
87.62%
Industry
145.39%
Market
16.85%
ATHE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ATHE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ATHE's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
ATHE revenue history
Current Revenue
$5.0M
Current Earnings
-$8.0M
Current Profit Margin
-159%
Be the first to know when ATHE announces revenue.
ATHE Revenue History By Year
| ATHE Yearly Revenue | ATHE Revenue | ATHE Change | ATHE Revenue Growth |
|---|---|---|---|
| 2025-06-30 | $5.03M | $2.35M | +87.62% |
| 2024-06-30 | $2.68M | -$21.40k | -0.79% |
| 2023-06-30 | $2.70M | -$857.08k | -24.09% |
| 2022-06-30 | $3.56M | $185.65k | +5.51% |
| 2021-06-30 | $3.37M | $3.29M | +3,884.34% |
| 2020-06-30 | $84.64k | -$3.40M | -97.57% |
| 2019-06-30 | $3.49M | $1.17M | +50.59% |
| 2018-06-30 | $2.32M | -$9.75k | -0.42% |
| 2017-06-30 | $2.33M | -$1.32M | -36.22% |
| 2016-06-30 | $3.65M | -$1.36M | -27.13% |
| 2015-06-30 | $5.00M | -$2.73M | -35.27% |
| 2014-06-30 | $7.73M | $3.49M | +82.28% |
| 2013-06-30 | $4.24M | $1.66M | +64.09% |
| 2012-06-30 | $2.58M | $2.41M | +1,380.01% |
| 2011-06-30 | $174.62k | -$7.44k | -4.08% |
| 2010-06-30 | $182.06k | -$164.38k | -47.45% |
| 2009-06-30 | $346.43k | -$124.88k | -26.50% |
| 2008-06-30 | $471.32k | $40.56k | +9.41% |
| 2007-06-30 | $430.76k | -$348.96k | -44.75% |
| 2006-06-30 | $779.72k | -$1.24M | -61.38% |
| 2005-06-30 | $2.02M | $407.15k | +25.26% |
| 2004-06-30 | $1.61M | $393.67k | +32.31% |
| 2003-06-30 | $1.22M | $770.99k | +172.36% |
| 2002-06-30 | $447.31k | $184.89k | +70.45% |
| 2001-06-30 | $262.42k | $215.26k | +456.45% |
| 2000-06-30 | $47.16k | N/A | N/A |
Alterity Therapeutics Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.